# The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients

> **NCT00002385** · NA · COMPLETED · sponsor: **Anderson Clinical Research** · enrollment: 60 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Fozivudine tidoxil

## Key facts

- **NCT ID:** NCT00002385
- **Lead sponsor:** Anderson Clinical Research
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002385, "The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00002385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*